Thursday 1 May 2014

Case Study: Designing Drugs Virtually

   Pharmaceutical companies and medical researchers are constantly trying to find new drugs that will provide better treatments for cancer and other serious illnesses. Until recently, this process was largely a matter of trial and error.

   Disease-fighting drugs typically work by attacking a disease-causing protein that is harmfully interacting with other molecules in the body. The drug is able to stop these interactions by connecting to the protein, and either restoring healthy interactions or compensating for the unhealthy ones. 






No comments:

Post a Comment